K. Michelle Peavy

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

“Hooked on” Prescription-Type Opiates Prior to Using Heroin: Results from a Survey of Syringe Exchange Clients

K. Michelle Peavy, Caleb J. Banta‐Green, Susan Kingston et al. · Journal of Psychoactive Drugs · 2012 · 129 citations

Opioid Epidemic, Substance Use, Drug Policy +19

Do Specialized Services Exist for LGBT Individuals Seeking Treatment for Substance Misuse? A Study of Available Treatment Programs

Bryan N. Cochran, K. Michelle Peavy, Jennifer S. Robohm · Substance Use & Misuse · 2007 · 122 citations

Substance Abuse Treatment Providers' Explicit and Implicit Attitudes Regarding Sexual Minorities

Bryan N. Cochran, K. Michelle Peavy, Ana Mari Cauce · Journal of Homosexuality · 2007 · 78 citations

Substance Use, Heterosexual Counselors, Substance Use Disorders +19

Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program

K. Michelle Peavy, James Darnton, Paul Grekin et al. · AIDS and Behavior · 2020 · 66 citations · Full text

Opioid Epidemic, Substance Use, Drug Treatment +18